Abeona Therapeutics Stock Forecast - Coefficient Of Variation

ABEO Stock  USD 6.41  0.38  6.30%   
Abeona Stock Forecast is based on your current time horizon. Although Abeona Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Abeona Therapeutics' systematic risk associated with finding meaningful patterns of Abeona Therapeutics fundamentals over time.
  
At this time, Abeona Therapeutics' Inventory Turnover is very stable compared to the past year. As of the 30th of November 2024, Payables Turnover is likely to grow to 1.62, while Receivables Turnover is likely to drop 1.36. . As of the 30th of November 2024, Common Stock Shares Outstanding is likely to grow to about 22.4 M, while Net Loss is likely to drop (41.1 M).
Abeona Therapeutics has current Coefficient Of Variation of 0.
Check Abeona Therapeutics VolatilityBacktest Abeona TherapeuticsInformation Ratio  

Abeona Therapeutics Trading Date Momentum

On November 30 2024 Abeona Therapeutics was traded for  6.41  at the closing time. The top price for the day was 6.55  and the lowest listed price was  6.01 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.99% .
Compare Abeona Therapeutics to competition

Other Forecasting Options for Abeona Therapeutics

For every potential investor in Abeona, whether a beginner or expert, Abeona Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Abeona Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Abeona. Basic forecasting techniques help filter out the noise by identifying Abeona Therapeutics' price trends.

Abeona Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abeona Therapeutics stock to make a market-neutral strategy. Peer analysis of Abeona Therapeutics could also be used in its relative valuation, which is a method of valuing Abeona Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Abeona Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Abeona Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Abeona Therapeutics' current price.

Abeona Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Abeona Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abeona Therapeutics shares will generate the highest return on investment. By undertsting and applying Abeona Therapeutics stock market strength indicators, traders can identify Abeona Therapeutics entry and exit signals to maximize returns.

Abeona Therapeutics Risk Indicators

The analysis of Abeona Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Abeona Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting abeona stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Abeona Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Abeona Stock

  0.78EWTX Edgewise TherapeuticsPairCorr
  0.64BHC Bausch Health CompaniesPairCorr

Moving against Abeona Stock

  0.52ELAN Elanco Animal HealthPairCorr
  0.46MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.46INAB In8bio IncPairCorr
  0.35HLN Haleon plcPairCorr
  0.34TAK Takeda PharmaceuticalPairCorr
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Abeona Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Abeona Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abeona Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abeona Therapeutics Stock:
Check out Historical Fundamental Analysis of Abeona Therapeutics to cross-verify your projections.
To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.05)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.38)
Return On Equity
(1.27)
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.